We are live on ! Find out more
SP

SIH Partners Portfolio holdings

AUM $7.58B
1-Year Est. Return 5.28%
This Fund
S&P 500
This Quarter Est. Return
+0.43%
1 Year Est. Return
+5.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.95B
AUM Growth
+$974M
Cap. Flow
+$1.05B
Cap. Flow %
35.62%
Top 10 Hldgs %
65.51%
Holding
315
New
184
Increased
39
Reduced
33
Closed
45

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.41%
2 Financials 5.13%
3 Healthcare 5.02%
4 Communication Services 1.71%
5 Materials 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADMA icon
201
ADMA Biologics
ADMA
$1.92B
$296K 0.01%
+14,897
New +$258K
SW
202
Smurfit Westrock
SW
$25.5B
$294K 0.01%
+6,522
New +$331K
CYTK icon
203
Cytokinetics
CYTK
$11B
$294K 0.01%
+7,307
New +$336K
BMO icon
204
Bank of Montreal
BMO
$125B
$287K 0.01%
+3,010
New +$298K
A icon
205
Agilent Technologies
A
$39.1B
$278K 0.01%
+2,375
New +$320K
UMC icon
206
CALL
United Microelectronic
UMC
$48.9B
$275K 0.01%
+38,500
New +$245K
SU icon
207
Suncor Energy
SU
$77.7B
$275K 0.01%
+7,099
New +$271K
RXRX icon
208
Recursion Pharmaceuticals
RXRX
$1.57B
$271K 0.01%
+51,202
New +$373K
DAVA icon
209
Endava
DAVA
$141M
$263K 0.01%
13,505
DXCM icon
210
DexCom
DXCM
$27.6B
$254K 0.01%
+3,726
New +$304K
PTCT icon
211
PTC Therapeutics
PTCT
$6.37B
$253K 0.01%
+4,962
New +$248K
HAFN icon
212
Hafnia
HAFN
$3.82B
$249K 0.01%
59,838
+10,210
+21% +$50.6K
IQV icon
213
IQVIA
IQV
$34.7B
$244K 0.01%
+1,385
New +$269K
CCJ icon
214
Cameco
CCJ
$38.3B
$235K 0.01%
+5,714
New +$269K
FNV icon
215
Franco-Nevada
FNV
$41.4B
$234K 0.01%
+1,483
New +$207K
XLP icon
216
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
$229K 0.01%
+2,805
New +$224K
ACLX
217
DELISTED
Arcellx
ACLX
$227K 0.01%
+3,461
New +$234K
MTD icon
218
Mettler-Toledo International
MTD
$26.8B
$224K 0.01%
+190
New +$243K
IDXX icon
219
Idexx Laboratories
IDXX
$42.9B
$224K 0.01%
+533
New +$231K
VCYT icon
220
Veracyte
VCYT
$4.52B
$222K 0.01%
+7,500
New +$286K
RNAM
221
DELISTED
Avidity Biosciences
RNAM
$222K 0.01%
+7,533
New +$235K
RYTM icon
222
Rhythm Pharmaceuticals
RYTM
$7B
$211K 0.01%
+3,980
New +$221K
RARE icon
223
Ultragenyx Pharmaceutical
RARE
$2.65B
$208K 0.01%
+5,738
New +$239K
USB icon
224
US Bancorp
USB
$99.6B
$206K 0.01%
+4,887
New +$225K
CM icon
225
Canadian Imperial Bank of Commerce
CM
$107B
$206K 0.01%
+3,652
New +$220K

Similar funds

SIH Partners's Q1 2025 Portfolio in Review

As of Q1 2025, SIH Partners held 315 positions worth $2.95B, up 49% from $1.98B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

SIH Partners deployed $1.05B of net new capital in Q1 2025, opening 184 new positions and adding to 39 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 2,828,497 shares worth $124M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $115M trimmed.

  • SIH Partners's largest Q1 2025 buy was iShares MSCI Emerging Markets ETF: 2,828,497 shares worth $124M.
  • SIH Partners added most to Stellantis in Q1 2025, an estimated $38.7M increase.
  • SIH Partners's biggest Q1 2025 reduction was iShares JPMorgan USD Emerging Markets Bond ETF, cutting an estimated $115M.
  • SIH Partners fully exited State Street SPDR S&P 500 ETF Trust in Q1 2025, selling an estimated $263M.
  • SIH Partners's ten largest holdings make up 66% of its $2.95B portfolio in Q1 2025.
  • SIH Partners opened 184 new positions and closed 45 in Q1 2025.
  • SIH Partners's portfolio value rose 49% quarter-over-quarter to $2.95B.

Based on SIH Partners's 13F filing for Q1 2025, filed 15 May 2025.